Epilepsy: Overcoming the Challenges of Today & Accelerating Toward Tomorrow

 

The first afternoon session includes the following topics:

  • Patient Engagement in Research
    Brandy E. Fureman, PhD, Program Director, National Institutes of Neurological Diseases and Stroke, National Institute of Health
    Janice Buelow RN, PhD, Vice-President, Programs and Research, Epilepsy Foundation
    Starts at 1:31 
     
  • The Personal Perspective
    Lisa Moss, Director, Donor Relations, Tuberous Sclerosis Alliance
    Starts at 30:26  
     
  • When Seizures Don't Respond to Medications
    Paul Garcia, MD, Professor of Clinical Neurology, Director, Clinical Epilepsy Services, University of California San Francisco
    Starts at 42:38 
     
  • New Approaches to Surgery
    Kurtis Auguste, MD, Assistant Professor of Pediatric Neurosurgery, University of California San Francisco
    Starts at 56:10 
     
  • Devices for Epilepsy
    Robert Fisher MD, PhD, Maslah Saul MD Professor of Neurology & Neurological Sciences, Director, Comprehensive Epilepsy Center, Stanford University School of Medicine
    Starts at 1:10:13
     
  • Panel Q&A moderated by Patricia Dean, ARNP, MSN, Clinical Coordinator, Pediatric Nurse Practitioner, Miami Children's Hospital Brain Institute
    Starts at 1:30:00

<< Previous Video:
Epilepsy Pipeline 2014 - Family Day, Part 2

>> Next Video:
Epilepsy Pipeline 2014 - Family Day, Part 4

ADVERTISEMENT
2014 Epilepsy Pipeline Conference

On June 5-7, 2014 in San Francisco, CA, the Epilepsy Therapy Project, an initiative of the Epilepsy Foundation presented the 4th Biennial Epilepsy Pipeline Conference 2014, held at the Hyatt Regency, San Francisco.

Showcasing the most promising epilepsy therapies from healthcare companies dedicated to pioneering and advancing drugs, biologics, technologies and devices for epilepsy and seizures, this year's conference featured the third annual "Shark Tank" competition, in addition to a day designated for people with epilepsy, families and advocates. The conference brought together decision-makers with a stake in the field of epilepsy treatment, therapeutic innovation and product development. Speakers and attendees included emerging biotech and medical technology companies, major pharmaceutical and device companies, and researchers and innovators at the cutting-edge of epilepsy and CNS treatment advances.

Read the press release for more information

ADVERTISEMENT